U.S. Global Investors (USGI)’s Quest Diagnostics DGX Stock Holding History

U.S. Global Investors (USGI)’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,600	Closed	-$461K	–	144
2018 Q1	$461K	Buy	4,600 +700	+18%	+$71.7K	0.28%	73
2017 Q4	$384K	Buy	+3,900	New	+$370K	0.18%	103
2017 Q3	–	Sell	-5,074	Closed	-$564K	–	154
2017 Q2	$564K	Sell	5,074 -826	-14%	-$87.3K	0.19%	85
2017 Q1	$579	Buy	5,900 +300	+5%	+$28.6K	﹤0.01%	88
2016 Q4	$515K	Buy	+5,600	New	+$483K	0.22%	97
2015 Q3	–	Sell	-3,800	Closed	-$276K	–	304
2015 Q2	$276K	Hold	3,800	–	–	0.11%	161
2015 Q1	$292K	Hold	3,800	–	–	0.08%	174
2014 Q4	$255K	Buy	3,800 +200	+6%	+$12.6K	0.07%	180
2014 Q3	$218K	Hold	3,600	–	–	0.06%	197
2014 Q2	$211K	Hold	3,600	–	–	0.05%	215
2014 Q1	$209K	Hold	3,600	–	–	0.03%	241
2013 Q4	$193K	Buy	+3,600	New	+$214K	0.03%	256

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

U.S. Global Investors (USGI)'s DGX Position: Q2 2018 in Review

U.S. Global Investors (USGI) sold out of Quest Diagnostics (DGX) in Q2 2018, closing a stake of 4,600 shares — an estimated $461K sold.

U.S. Global Investors (USGI) first reported a position in DGX in Q4 2013 and held it in 12 quarters. The position peaked at $564K in Q2 2017. 662 funds tracked by Wall St. Rank hold DGX as of Q2 2018.

U.S. Global Investors (USGI) reported no remaining Quest Diagnostics position as of Q2 2018 after selling out during the quarter.
U.S. Global Investors (USGI) sold 4,600 Quest Diagnostics shares in Q2 2018, an estimated $461K.
U.S. Global Investors (USGI) first reported a position in Quest Diagnostics in Q4 2013 and held it in 12 quarters.
U.S. Global Investors (USGI)'s Quest Diagnostics position peaked at $564K in Q2 2017.
662 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2018.

Based on U.S. Global Investors (USGI)'s 13F filing for Q2 2018, filed 14 Aug 2018.